Clinical Trial Update: Extension Study Evaluating Etanercept in Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

An extension Phase 4 trial evaluating etanercept in ankylosing spondylitis completed, with results posted in May 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Enbrel (Etanercept) (Etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED | Results posted: 2012-05-11